The field of medicine is on the verge of a revolution driven by CRISPR gene-editing technology. After decades of research, the first CRISPR-based therapies are now being approved to treat genetic diseases like sickle cell anemia. Scientists are exploring its potential to tackle a wide range of conditions, from rare genetic disorders to common diseases like cancer and heart disease. This article explores the immense promise of CRISPR while also touching on the ethical and safety considerations that accompany this powerful technology.
